GREENLAND MINES LTD Proceeds from Unsecured Notes Payable
GREENLAND MINES LTD (GRML) reported Proceeds from Unsecured Notes Payable of $120.00 thousand for the 1-month period ending 2023-09-25, per its 10-Q filed 2023-11-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromUnsecuredNotesPayable · last filed 2024-05-23
- 2023-09-25: Proceeds from Unsecured Notes Payable 1 month $120.00K.
- 2023-08-29: Proceeds from Unsecured Notes Payable $150.00K; Proceeds from Unsecured Notes Payable 1 month $150.00K.
| Period end | Proceeds from Unsecured Notes Payable | Proceeds from Unsecured Notes Payable 1 month |
|---|---|---|
| 2023-09-25 | $120.00K 10-Q · filed 2023-11-17 | |
| 2023-08-29 | $150.00K 10-Q · filed 2024-05-23 | $150.00K 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |